← Leaderboards
Michael Klagsbrun
Children'S Hospital Boston
$9,114,200
Attributed
$9,114,200
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$9,114,200 · 6
By mechanism
R37$5,630,116 · 1
R01$1,443,624 · 2
P01$1,238,430 · 1
P50$417,654 · 1
R56$384,376 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Arthur M Mercurio$23,862,191
- David Michael Briscoe$31,770,341
- Joyce E. Bischoff$21,924,378
- Michael R Freeman$18,313,322
- Michael Klagsburn$483,841
Others in their field
Top investigators on “Vascular Endothelial Growth Factors”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Michael Simons · Yale University$37,207,792
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Shahin Rafii · Weill Medical College Of Cornell Univ$24,406,332
- Rakesh K. Jain · Massachusetts General Hospital$23,479,897
- Aleksander S. Popel · Johns Hopkins University$19,039,579
Research focus
Vascular Endothelial Growth FactorsAngiogenesisCell MotilityProtein Structure FunctionNeoplastic CellIn Situ HybridizationGrowth Factor ReceptorsHeparinCell ProliferationYeast Two Hybrid SystemLaboratory RatMalignant NeoplasmsRegulationReceptor BindingTissue /Cell CultureFamilyTumor AngiogenesisMolecular CloningTumor GrowthEpidermal Growth FactorGene ExpressionNeuropilinsGenetic Promoter ElementLaboratory Mouse
Grant awards (23)
Neuropilin and Semaphorin Function in Development and Tumor Angiogenesis$307,845
P01 · FY2011 · CA · contact PI
Neuropilin and Semaphorin Function in Development and Tumor Angiogenesis$317,363
P01 · FY2010 · CA · contact PI
Neuropilin and semaphorin, anti-angiogenesis activities and mechanisms$384,376
R56 · FY2009 · CA · contact PI
Neuropilin and Semaphorin Function in Development and Tumor Angiogenesis$311,145
P01 · FY2009 · CA · contact PI
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$683,003
R37 · FY2008 · CA · contact PI
Circulating Inhibitors of Endothelial Cell Growth$311,052
R01 · FY2008 · CA · contact PI
Neuropilin and Semaphorin Function in Development and Tumor Angiogenesis$302,077
P01 · FY2008 · CA · contact PI
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$676,241
R37 · FY2007 · CA · contact PI
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$676,153
R37 · FY2006 · CA · contact PI
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$669,284
R37 · FY2005 · CA
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$594,126
R37 · FY2004 · CA
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$582,802
R37 · FY2003 · CA
HB-EGF AND ITS RECEPTORS$283,143
R01 · FY2003 · GM
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$567,936
R37 · FY2002 · CA
HB-EGF AND ITS RECEPTORS$283,143
R01 · FY2002 · GM
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$552,589
R37 · FY2001 · CA
HB-EGF AND ITS RECEPTORS$283,143
R01 · FY2001 · GM
HEPARIN BINDING GROWTH FACTORS IN THE RESPONSE TO LUNG INJURY$208,827
P50 · FY2001 · HL
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$45,610
R37 · FY2001 · CA
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$537,690
R37 · FY2000 · CA
HB-EGF AND ITS RECEPTORS$283,143
R01 · FY2000 · GM
HEPARIN BINDING GROWTH FACTORS IN THE RESPONSE TO LUNG INJURY$208,827
P50 · FY2000 · HL
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR$44,682
R37 · FY2000 · CA